Farabi Pharmaceutical (XTEH:DFRB1) Market Cap: IRR0.00 Mil (As of Jul. 06, 2026)


What is Farabi Pharmaceutical Market Cap?

Farabi Pharmaceutical XTEH:DFRB1 Market Cap is IRR0.00 Mil as of Jul. 06, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Farabi Pharmaceutical's share price for the quarter that ended in . 20 was IRR. Farabi Pharmaceutical's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Farabi Pharmaceutical's market cap for the quarter that ended in . 20 was IRR Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Farabi Pharmaceutical's Enterprise Value for Today is IRR0.00 Mil.

Farabi Pharmaceutical  (XTEH:DFRB1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Farabi Pharmaceutical Market Cap Related Terms

Farabi Pharmaceutical Market Cap Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Market Cap Chart

Farabi Pharmaceutical Annual Data
Trend
Market Cap

Farabi Pharmaceutical Quarterly Data
Market Cap

XTEH:DFRB1 vs IMNPQ, INNV: Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Market Cap distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Market Cap falls into.


Farabi Pharmaceutical Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Farabi Pharmaceutical's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )=Share Price (A: . 20 )*Shares Outstanding (EOP) (A: . 20 )
=IRR*
=IRR

Farabi Pharmaceutical's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )=Share Price (Q: . 20 )*Shares Outstanding (EOP) (Q: . 20 )
=IRR*0
=IRR

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of IRR0.00 Mil mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Market Cap of IRR0.00 Mil as of Jul. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Market Cap too high?
Farabi Pharmaceutical's current Market Cap is IRR0.00 Mil.
How does Farabi Pharmaceutical's Market Cap compare to IMNPQ and INNV?
Farabi Pharmaceutical's Market Cap of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 214.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 214.89, based on 1,024 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Market Cap is 214.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current Market Cap is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Market Cap of IRR0.00 Mil. The current Market Cap is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Market Cap is IRR0.00 Mil as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.